Literature DB >> 19887766

Erythema multiforme following vaccination for human papillomavirus.

A C Katoulis1, A Liakou, E Bozi, M Theodorakis, A Alevizou, A Zafeiraki, M Mistidou, N G Stavrianeas.   

Abstract

Erythema multiforme (EM) is an acute self-limited immune-mediated reaction manifested by target skin lesions with mucous membrane involvement. The most common causes are infections and drugs. Vaccinations have been reported as a triggering factor, and they may be a frequent cause of EM in childhood. A 19-year-old female developed several target lesions of the hands and feet 10 days after the second dose of human papillomavirus (HPV) vaccine. Clinico-histologically, a diagnosis of EM minor was made. Treatment with topical corticosteroids and oral antihistamines resulted in complete clearance of the rash. Four months later, she received the last booster dose of the vaccine. A few subtle lesions appeared and disappeared spontaneously after a few days. Gardasil is a non-infectious vaccine, developed for the prevention of cervical cancer, precancerous genital lesions and genital warts. It delivers the major capsid (L1) protein of HPV types 6, 11, 16 and 18. Mild local reactions are the main adverse events. The only serious events are very rare cases of anaphylaxis. In our patient, the temporal relationship between the development of EM and the vaccination suggests that the HPV vaccine probably was the causal agent. This is the first published case of EM following HPV vaccination. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19887766     DOI: 10.1159/000254898

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  9 in total

1.  Review of Gardasil.

Authors:  Diane M Harper; Stephen L Vierthaler; Jennifer A Santee
Journal:  J Vaccines Vaccin       Date:  2010-11-23

2.  Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999-2017.

Authors:  John R Su; Penina Haber; Carmen S Ng; Paige L Marquez; Graça M Dores; Silvia Perez-Vilar; Maria V Cano
Journal:  Vaccine       Date:  2019-12-20       Impact factor: 3.641

3.  Vaccination against HPV-Associated Neoplasias: Recommendations from the Current S3 Guideline of the HPV Management Forum of the Paul-Ehrlich Society - AWMF Guidelines, Registry No. 082-002 (short version), valid until Dec. 31st, 2018.

Authors:  G Gross; N Becker; N H Brockmeyer; S Esser; U Freitag; M Gebhardt; L Gissmann; P Hillemanns; H Grundhewer; H Ikenberg; H Jessen; A Kaufmann; S Klug; J P Klußmann; A Nast; D Pathirana; K U Petry; H Pfister; U Röllinghof; P Schneede; A Schneider; E Selka; S Singer; S Smola; B Sporbeck; M von Knebel Doeberitz; P Wutzler
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-03       Impact factor: 2.915

4.  Toxic epidermal necrolysis with ocular involvement following vaccination for hemorrhagic fever with renal syndrome.

Authors:  Young Hoon Hwang; Myung Seung Kang; Kyung O Lim; Sang Mok Lee
Journal:  Yonsei Med J       Date:  2012-01       Impact factor: 2.759

Review 5.  Pityriasis Lichenoides et Varioliformis Acuta Triggered by Human Papillomavirus Vaccine: A Case Report and Literature Review.

Authors:  Beata A Jastrząb; Aleksandra A Stefaniak; Anita Hryncewicz-Gwóźdź; Piotr Nockowski; Jacek C Szepietowski
Journal:  Acta Derm Venereol       Date:  2021-09-17       Impact factor: 3.875

6.  Simultaneous Development of Gianotti-Crosti Syndrome and Erythema Multiforme Following Second Dose of Measles-rubella Vaccine.

Authors:  Masahiro Oka
Journal:  Acta Derm Venereol       Date:  2021-04-26       Impact factor: 3.875

7.  Childhood erythrodermic lichen planus pemphigoides after nonavalent human papillomavirus vaccination.

Authors:  Laura Pizzatti; Caterina Ferreli; Brunella Conti; Laura Atzori; Giampietro Pinna; Luca Pilloni; Franco Rongioletti
Journal:  JAAD Case Rep       Date:  2020-04-30

8.  Generalized erythema multiforme-like skin rash following the first dose of COVID-19 vaccine (Pfizer-BioNTech).

Authors:  M J Kim; J W Kim; M S Kim; S Y Choi; J I Na
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-11-03       Impact factor: 9.228

Review 9.  Drug-related Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Review.

Authors:  Rohini Arora; Rajesh K Pande; Shikha Panwar; Vivek Gupta
Journal:  Indian J Crit Care Med       Date:  2021-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.